Clinical trial
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT01707381
Study timeline
Study start (unknown)2012-11-01Date precision: month
Registry last updated2018-09-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Ocular Hypertensionunresolved
Open Angle Glaucomaunresolved
Interventions
BOL-303259-XDRUG
Timolol maleateDRUG · verified · RxNorm: timolol maleate
Sponsors & collaborators
Bausch & Lomb Incorporatedlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01707381 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.